Imatinib Terminated Phase 2 Trials for chronic Chronic myelogenous leukemia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00415909TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients